The HDAC inhibitor sodium butyrate increases ABCB1 expression in lung and colorectal cancer cells by elevating H3K9ac levels through the inhibition of HDAC4 (Shi et al., 2020). This evidence concerns the gene HDAC4 and colorectal cancer.